Technical Analysis for BCDA - BioCardia, Inc.

Grade Last Price % Change Price Change
D 3.68 0.00% 0.00
BCDA closed unchanged on Thursday, April 22, 2021, on 33 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical BCDA trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness 5.44%
Below Lower BB Weakness 5.44%
Down 3 Days in a Row Weakness 5.44%
Older End-of-Day Signals for BCDA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 4 hours ago
Down 2 % about 4 hours ago
Down 1% about 4 hours ago
Up 3% about 4 hours ago
Up 2% about 4 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia. The company is also developing CardiALLO Cell Therapy System, an investigational culture expanded bone marrow derived from mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system; and Morph vascular access product line, which provides catheter products. BioCardia, Inc. is based in San Carlos, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Bone Stem Cells Catheter Cardiovascular Disease Heart Failure Cell Therapy Regenerative Medicine Vascular Diseases Cardiovascular Diseases Bone Marrow Vascular Access Aging Associated Diseases Ischemia Heart Diseases Treatment Of Heart Failure

Is BCDA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.6
52 Week Low 1.91
Average Volume 176,017
200-Day Moving Average 3.16
50-Day Moving Average 4.16
20-Day Moving Average 4.11
10-Day Moving Average 3.92
Average True Range 0.31
ADX 21.89
+DI 22.72
-DI 23.21
Chandelier Exit (Long, 3 ATRs ) 3.96
Chandelier Exit (Short, 3 ATRs ) 4.34
Upper Bollinger Band 4.71
Lower Bollinger Band 3.51
Percent B (%b) 0.14
BandWidth 29.40
MACD Line -0.13
MACD Signal Line -0.05
MACD Histogram -0.0781
Fundamentals Value
Market Cap 45.74 Million
Num Shares 12.4 Million
EPS -3.20
Price-to-Earnings (P/E) Ratio -1.15
Price-to-Sales 66.80
Price-to-Book 7.46
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.02
Resistance 3 (R3) 4.03 3.93 3.96
Resistance 2 (R2) 3.93 3.84 3.92 3.94
Resistance 1 (R1) 3.80 3.79 3.87 3.79 3.93
Pivot Point 3.70 3.70 3.73 3.70 3.70
Support 1 (S1) 3.58 3.62 3.64 3.57 3.43
Support 2 (S2) 3.48 3.56 3.47 3.42
Support 3 (S3) 3.35 3.48 3.40
Support 4 (S4) 3.34